Molecular selection for therapy of patients with non-small-cell lung cancer and impaired performance status: Has the time come?

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)232-234
Number of pages3
JournalClinical Lung Cancer
Volume7
Issue number4
StatePublished - Jan 2006

Fingerprint

Protein Kinase Inhibitors
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Antineoplastic Agents
Patient Selection
Lung Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Pulmonary and Respiratory Medicine

Cite this

@article{651445f6f5ec4d8e9469e48519f488d5,
title = "Molecular selection for therapy of patients with non-small-cell lung cancer and impaired performance status: Has the time come?",
author = "Lara, {Primo N}",
year = "2006",
month = "1",
language = "English (US)",
volume = "7",
pages = "232--234",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Molecular selection for therapy of patients with non-small-cell lung cancer and impaired performance status

T2 - Has the time come?

AU - Lara, Primo N

PY - 2006/1

Y1 - 2006/1

UR - http://www.scopus.com/inward/record.url?scp=33244461548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244461548&partnerID=8YFLogxK

M3 - Article

C2 - 16512975

AN - SCOPUS:33244461548

VL - 7

SP - 232

EP - 234

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 4

ER -